ACHC:NSD-Acadia Healthcare Company Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 71.87

Change

+0.29 (+0.41)%

Market Cap

USD 6.51B

Volume

0.81M

Avg Analyst Target

USD 80.67 (+12.24%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


ACHC Stock Forecast & Price:
Based on the Acadia Healthcare Company Inc stock forecasts from 5 analysts, the average analyst target price for Acadia Healthcare Company Inc is USD 80.67 over the next 12 months. Acadia Healthcare Company Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Acadia Healthcare Company Inc is Neutral, which is based on 5 positive signals and 6 negative signals. At the last closing, Acadia Healthcare Company Inc’s stock price was USD 71.87. Acadia Healthcare Company Inc’s stock price has changed by +4.08% over the past week, +1.31% over the past month and +13.29% over the last year.

About Acadia Healthcare Company Inc (ACHC:NSD)

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-07-05 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LHCG LHC Group

+0.91 (+0.59%)

USD4.81B 48.15 24.66
ENSG The Ensign Group Inc

-0.44 (-0.58%)

USD4.20B 21.94 16.15
AMED Amedisys Inc

+4.56 (+4.11%)

USD3.76B 18.82 12.08
SGRY Surgery Partners Inc

+0.26 (+0.83%)

USD2.81B 63.00 13.11
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
AMEH Apollo Medical Holdings Inc

+2.84 (+7.36%)

USD1.87B 25.27 17.07
TVTY Tivity Health Inc

N/A

USD1.62B 19.06 12.00
ADUS Addus HomeCare Corporation

+0.37 (+0.44%)

USD1.37B 30.03 18.80
HCSG Healthcare Services Group Inc

-0.07 (-0.40%)

USD1.30B 40.93 19.28
CCRN Cross Country Healthcare Inc

+0.01 (+0.05%)

USD0.81B 4.50 4.57

ETFs Containing ACHC

Symbol Name Weight Mer Price(Change) Market Cap
CHEP AGFiQ U.S. Market Neutral.. 0.00 % 1.42 %

N/A

USD0.75M
2B77:XETRA iShares Ageing Population.. 0.00 % 0.40 %

N/A

USD0.84B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.40% 91% A- 96% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.40% 91% A- 96% A
Trailing 12 Months  
Capital Gain 14.84% 90% A- 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.84% 90% A- 93% A
Trailing 5 Years  
Capital Gain 50.45% 43% F 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.45% 43% F 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 23.18% 57% F 79% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.18% 57% F 79% C+
Risk Return Profile  
Volatility (Standard Deviation) 61.57% 43% F 23% F
Risk Adjusted Return 37.64% 52% F 69% D+
Market Capitalization 6.51B 100% A+ 90% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.49 50% F 33% F
Price/Book Ratio 2.52 52% F 34% F
Price / Cash Flow Ratio 17.39 30% F 17% F
EV/EBITDA 15.93 43% F 18% F
Management Effectiveness  
Return on Equity 9.88% 70% C- 66% D
Return on Invested Capital 7.28% 54% F 68% D+
Return on Assets 5.44% 70% C- 82% B-
Debt to Equity Ratio 58.73% 35% F 33% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 8.51 30% F 15% F
Short Percent 4.65% 61% D- 38% F
Beta 1.28 37% F 37% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector